Although my primary focus remains the trigeminal nerve and the pain that arises from its damage, I intend to also share information about other facial neuralgias, and more broadly, various neuropathic pain conditions on this page.
I believe that raising awareness about less-discussed facial pain syndromes and neuropathy in general can be highly valuable — both for us as patients and for those involved in pain diagnosis and treatment.
One such condition is glossopharyngeal neuralgia — a rare disorder that is potentially very debilitating and sometimes dangerous.
Definition and characteristics
Glossopharyngeal neuralgia (cranial nerve IX) is a rare pain syndrome characterized by paroxysmal, unilateral pain of very high intensity.
Symptoms typically involve:
- The base of the tongue
- The posterior pharyngeal wall
- The tonsillar area
- The Eustachian tube opening
- The external ear canal
- The mastoid process and jaw angle areas
The pain is:
- Sharp
- Piercing
- "Electric"
- Brief (from seconds to approximately 2 minutes)
Attacks can be triggered by stimuli such as:
- Swallowing
- Speaking
- Chewing
- Coughing
- Yawning
- Touching specific zones (trigger points)
A distinctive feature of this neuralgia is the possibility of cardiac symptoms — bradycardia, blood pressure drops, and even loss of consciousness (so-called MAS attacks), which makes this condition potentially life-threatening.
Why?
Because they can lead to sudden cerebral hypoxia, falls, injuries, and in extreme cases, even cardiac arrest.
What are MAS attacks?
MAS (Morgagni-Adams-Stokes) attacks are brief episodes of loss of consciousness caused by sudden cardiac rhythm disturbances.
Key points:
- They most often result from severe bradycardia or momentary cardiac arrest
- They cause reduced blood flow to the brain
- They manifest as sudden syncope, sometimes with seizures
- They usually resolve spontaneously but are potentially dangerous
- In severe cases, a pacemaker may be required
History
The first descriptions of pain corresponding to glossopharyngeal neuralgia appeared in the early twentieth century. In 1910, Theodore Herman Weisenburg described a patient with a cerebellopontine angle tumor who experienced characteristic pain — initially misattributed to trigeminal neuralgia.
The term "glossopharyngeal neuralgia" was introduced in 1921 by Wilfred Harris, who drew attention to the connection between the pain and activities such as speaking or swallowing.
In subsequent years:
- Reichert described neuralgia associated with the tympanic nerve (a branch of nerve IX)
- Wortis and colleagues first noted the association between neuralgia and cardiac rhythm disturbances
- Sicard and Robineau performed the first successful surgical treatment
- Ekbom and Westerberg introduced effective pharmacological treatment (carbamazepine)
Classification
According to the International Classification of Orofacial Pain (ICOP), glossopharyngeal neuralgia includes paroxysmal pain in its innervation territory, often with vagal nerve involvement.
Diagnostic criteria:
- Recurrent, unilateral pain attacks
- Duration: seconds to 2 minutes
- Very high intensity
- Stabbing/electric character
- Provoked by physiological activities
- No other cause of pain identified
Epidemiology
Glossopharyngeal neuralgia is a rare condition:
- Incidence: approximately 0.7 per 100,000 persons per year
- Occurs mainly after age 50
- Approximately 100 times rarer than trigeminal neuralgia
It may be:
- Unilateral (most common)
- Rarely bilateral
Clinical symptoms
Key symptoms:
- Paroxysmal, severe pain in characteristic locations
- Duration up to 2 minutes
- Pain-free intervals between attacks
Triggering factors:
- Eating (cold, hot, sour, or sweet foods)
- Head and neck movements
- Touch
Accompanying symptoms:
- Tinnitus
- Dizziness
- Nausea
- Cardiac rhythm disturbances
In severe cases, Morgagni-Adams-Stokes attacks may occur, leading to loss of consciousness.
Classification by type
By location:
- Auricular type
- Oropharyngeal type
By etiology:
Idiopathic form — Most common; often associated with vascular compression of the nerve.
Secondary form — Causes include:
- Tumors
- Trauma
- Infections
- Demyelinating changes
- Surgical procedures
- Eagle syndrome
- Vascular malformations
Diagnosis
The foundation is a detailed history and analysis of pain characteristics.
Ancillary studies:
- MRI/MRA — detection of compression or demyelinating changes
- Angiography — vascular assessment
- Laboratory tests — exclusion of inflammatory conditions
- ECG — assessment of cardiac rhythm
- Panoramic X-ray (in diagnosing Eagle syndrome)
A diagnostic lidocaine block is also an important test.
Treatment
Pharmacological treatment
First-line medications:
- Carbamazepine
- Gabapentin
- Pregabalin
Others:
- Duloxetine
- Baclofen
- Lamotrigine
NSAIDs and opioids are usually ineffective.
Nerve blocks
Used when pharmacotherapy is ineffective:
- Lidocaine
- Bupivacaine
- Sometimes corticosteroids
Routes of administration: intraoral or extraoral.
Risks: vascular damage, swallowing disturbances, vagal nerve effects.
Surgical treatment
Indicated in refractory cases:
- Microvascular decompression
- Rhizotomy
- Neurotomy
- Tractotomy
In secondary forms: treatment of the underlying cause (e.g., tumor, malformation).
In cases with MAS attacks: pacemaker implantation.
Summary
Glossopharyngeal neuralgia is a rare but highly characteristic condition. Its diagnosis is based primarily on the clinical picture, and treatment often requires a multi-stage approach — from pharmacotherapy to surgical intervention.
Due to the possibility of cardiac complications, this condition has significance not only neurologically but also systemically. Proper diagnosis and prompt initiation of treatment can significantly improve patients' quality of life and, in some cases, prevent serious complications.
Has anyone here encountered glossopharyngeal neuralgia before? If anyone suffers from it — does the pain truly have the character and course described in the clinical symptoms?
Reference:
*Neuralgię twarzowe* (Facial Neuralgias) — I. Domitrz, W. Kozubski, J. Kochanowski, A. Stępień
Natalia — since 2014 I've been living with trigeminal nerve pain. I write in plain language, based on reliable sources and personal experience. Read my story →
Frequently Asked Questions
What is trigeminal neuralgia?
Trigeminal neuralgia is a chronic facial pain condition. It manifests as sudden, severe, usually one-sided pain attacks — often described as an electric shock. A single attack typically lasts from a few seconds to about two minutes.
What is the difference between neuralgia and neuropathy?
In simple terms: neuralgia primarily involves paroxysmal pain along a nerve, usually without loss of sensation. Neuropathy involves nerve damage that more often causes constant pain along with numbness and sensory loss.
Do regular painkillers help with neuropathic pain?
Usually not. Neuropathic pain responds poorly to paracetamol or anti-inflammatory drugs. Instead, medications that act on nerves are used, such as anticonvulsants like carbamazepine.
How does carbamazepine work for trigeminal neuralgia?
Carbamazepine is the first-line medication for trigeminal neuralgia. In a large proportion of patients, it provides effective pain control. It requires gradual dose adjustment and medical supervision.
What is the difference between gabapentin and pregabalin?
Both are anticonvulsant medications used for neuropathic pain. They differ in absorption and dosing characteristics. The choice and dosage should be determined by a physician.
Related Articles
Gabapentin and Pregabalin for Trigeminal Neuralgia
Gabapentin and pregabalin are antiepileptic drugs commonly used to treat trigeminal neuralgia and other types of neuropathic pain. They work by calming ove…
Carbamazepine for Trigeminal Neuralgia: Benefits, Risks, and Why It Works
Some time ago I wrote posts about gabapentin and pregabalin, so the time has come for carbamazepine. For me, it was a medication that became a true "game o…
Pregabalin and Weight Gain: What Patients with Trigeminal Neuralgia Should Know
Pregabalin needs no introduction here... a medication that for many people with neuropathic pain or trigeminal neuralgia is an enormous source of support.
Track your attacks, triggers, and medications — and show your doctor a clear picture of your condition.